WHAT LEGISLATIVE REMEDIES do we have for the bioterrorism and biowarfare problems? Does our system of open publication help or hinder? Do multinational agreements have any value if covert R&D appears inevitable and verification is all but impossible in a day when information is the key, rather than the pathogens themselves? The following string of blogs looks lightly at these questions.
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022